title: [Streptococcus agalactiae in nonpregnant adults].
abstract: The pathogenic capacity of streptococcus agalactiae or Group B Streptococcus (GBS) has been increasing in nonpregnant adults. We carried out a study about the pathogenic capacity and susceptibility to antibiotics of GBS strains isolated between January 2003 and June 2004 in Farhat Hached hospital of Sousse (Tunisian general hospital).
  
  
  METHODS
  Identification of strains was carried out according to usual bacteriological characters. Susceptibility of GBS to antibiotics was carried out according to CA-SFM recommendations.
  
  
  RESULTS
  during the study period, sixty strains were isolated. They were essentially isolated from the urinary tract (52%) and the skin (36.2%). Women accounted for 68 percent of the cases. Among the 30 hospitalized patients, 20 (66%) had serious underlying disease. Diabetes mellitus was predominant (80%). All group B streptococci isolates were susceptible to amoxicillin, penicillin G, vancomycin and to pristinamycin. Sixty four percent of isolates were susceptible to erythromycin. Among the invasive infection, caused by GBS in nonpregnant adults, skin and urinary tract infections were the most common. All isolates were susceptible to amoxicillin, penicillin G. vancomycin and to pristinamycin.
authors.affiliation: Laboratoire de Microbiologie, CHU Farhat Hached Sousse, Tunisie.
authors.forename: Adnène
authors.initials: A
authors.lastname: Toumi
authors.forename: Asma
authors.initials: A
authors.lastname: Ferjani
authors.forename: Hajer
authors.initials: H
authors.lastname: Ben Abdallah
authors.forename: Jalel
authors.initials: J
authors.lastname: Boukadida
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D012874:Skin Diseases, Infectious / Q000188:drug therapy / Q000382:microbiology; D013290:Streptococcal Infections / Q000188:drug therapy / Q000453:epidemiology*; D013292:Streptococcus agalactiae / Q000302:isolation & purification*; D014416:Tunisia / Q000453:epidemiology; D014552:Urinary Tract Infections / Q000188:drug therapy / Q000382:microbiology
chemical_list: D000900:Anti-Bacterial Agents